Tenax Therapeutics's total assets for Q3 2024 were $99.78M, an increase of 839.87% from the previous quarter. TENX total liabilities were $2.56M for the fiscal quarter, a 47.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.